Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objectives of the study are to: • Assess the safety profile and pharmacokinetics (PK) of venetoclax in combination with azacitidine • Determine the recommended dose (RD) and dosing schedule of venetoclax in combination with azacitidine • Determine the overall response rate of venetoclax in combination with azacitidine and of azacitidine monotherapy
Critère d'inclusion
- Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)